JP2013544285A5 - - Google Patents

Download PDF

Info

Publication number
JP2013544285A5
JP2013544285A5 JP2013542100A JP2013542100A JP2013544285A5 JP 2013544285 A5 JP2013544285 A5 JP 2013544285A5 JP 2013542100 A JP2013542100 A JP 2013542100A JP 2013542100 A JP2013542100 A JP 2013542100A JP 2013544285 A5 JP2013544285 A5 JP 2013544285A5
Authority
JP
Japan
Prior art keywords
hydroxylamine
triazin
propylamino
bis
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013542100A
Other languages
English (en)
Japanese (ja)
Other versions
JP5907986B2 (ja
JP2013544285A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/062386 external-priority patent/WO2012074999A1/en
Publication of JP2013544285A publication Critical patent/JP2013544285A/ja
Publication of JP2013544285A5 publication Critical patent/JP2013544285A5/ja
Application granted granted Critical
Publication of JP5907986B2 publication Critical patent/JP5907986B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013542100A 2010-11-29 2011-11-29 呼吸制御障害または呼吸制御疾患の処置用の呼吸刺激薬としての化合物 Active JP5907986B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41777710P 2010-11-29 2010-11-29
US61/417,777 2010-11-29
US201161494268P 2011-06-07 2011-06-07
US61/494,268 2011-06-07
PCT/US2011/062386 WO2012074999A1 (en) 2010-11-29 2011-11-29 Novel compounds as respiratory stimulants for treatment of breathing control disorders or diseases

Publications (3)

Publication Number Publication Date
JP2013544285A JP2013544285A (ja) 2013-12-12
JP2013544285A5 true JP2013544285A5 (cg-RX-API-DMAC7.html) 2015-03-12
JP5907986B2 JP5907986B2 (ja) 2016-04-26

Family

ID=46162783

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013542100A Active JP5907986B2 (ja) 2010-11-29 2011-11-29 呼吸制御障害または呼吸制御疾患の処置用の呼吸刺激薬としての化合物

Country Status (11)

Country Link
US (2) US9351972B2 (cg-RX-API-DMAC7.html)
EP (1) EP2646423A4 (cg-RX-API-DMAC7.html)
JP (1) JP5907986B2 (cg-RX-API-DMAC7.html)
KR (1) KR20140049961A (cg-RX-API-DMAC7.html)
CN (1) CN103347866B (cg-RX-API-DMAC7.html)
AU (1) AU2011336764B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013013429A2 (cg-RX-API-DMAC7.html)
CA (1) CA2819333A1 (cg-RX-API-DMAC7.html)
SG (2) SG10201601507YA (cg-RX-API-DMAC7.html)
WO (1) WO2012074999A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201303960B (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108524505A (zh) 2009-03-13 2018-09-14 安吉奥斯医药品有限公司 用于细胞增殖相关病症的方法和组合物
PT2448582T (pt) 2009-06-29 2017-07-10 Agios Pharmaceuticals Inc Compostos e composições terapêuticas
ES2594402T3 (es) 2009-10-21 2016-12-20 Agios Pharmaceuticals, Inc. Métodos y composiciones para trastornos relacionados con la proliferación celular
SG194697A1 (en) 2011-05-03 2013-12-30 Agios Pharmaceuticals Inc Pyruvate kinase activators for use in therapy
CN102827170A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
CN102827073A (zh) 2011-06-17 2012-12-19 安吉奥斯医药品有限公司 治疗活性组合物和它们的使用方法
ES2575710T3 (es) 2011-09-22 2016-06-30 Pfizer Inc Derivados de pirrolopirimidina y purina
SI2800743T1 (en) 2012-01-06 2018-08-31 Agios Pharmaceuticals, Inc. Therapeutically active compounds and methods for their use
US9474779B2 (en) 2012-01-19 2016-10-25 Agios Pharmaceuticals, Inc. Therapeutically active compositions and their methods of use
HK1209118A1 (en) * 2012-05-29 2016-03-24 Galleon Pharmaceuticals, Inc. Novel compounds and compositions for treatment of breathing control disorders or diseases
NZ706999A (en) 2012-10-15 2018-12-21 Agios Pharmaceuticals Inc Inhibitors of mutant isocitrate dehydrogenase and therapeutical uses thereof
JP2015537032A (ja) * 2012-11-15 2015-12-24 ガリオン ファーマシューティカルズ インコーポレイテッド 経口バイオアベイラビリティーを有する呼吸制御調節化合物およびそれを使用する方法
WO2014151462A1 (en) * 2013-03-15 2014-09-25 Galleon Pharmaceuticals, Inc. Novel breathing control modulating compounds, and methods of using same
US9579324B2 (en) 2013-07-11 2017-02-28 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
WO2015003360A2 (en) * 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
NZ715738A (en) 2013-07-11 2021-06-25 Agios Pharmaceuticals Inc N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as idh2 mutants inhibitors for the treatment of cancer
WO2015003355A2 (en) 2013-07-11 2015-01-15 Agios Pharmaceuticals, Inc. Therapeutically active compounds and their methods of use
US10376510B2 (en) 2013-07-11 2019-08-13 Agios Pharmaceuticals, Inc. 2,4- or 4,6-diaminopyrimidine compounds as IDH2 mutants inhibitors for the treatment of cancer
US20150031627A1 (en) 2013-07-25 2015-01-29 Agios Pharmaceuticals, Inc Therapeutically active compounds and their methods of use
CN112159391A (zh) 2014-03-14 2021-01-01 阿吉奥斯制药公司 治疗活性化合物的药物组合物
SI3307271T1 (sl) 2015-06-11 2023-11-30 Agios Pharmaceuticals, Inc. Postopki za uporabo aktivatorjev piruvat kinaze
KR102207539B1 (ko) * 2015-06-30 2021-01-26 네우라드 리미티드 신규한 호흡 제어 조절 화합물, 및 그의 제조 및 사용 방법
HUE057263T2 (hu) 2015-10-15 2022-04-28 Servier Lab Kombinációs terápia rosszindulató betegségek kezelésére
EP3362065B1 (en) 2015-10-15 2024-04-03 Les Laboratoires Servier Combination therapy comprising ivosidenib, cytarabine and daunorubicin or idarubicin for treating acute myelogenous leukemia
JP2020536045A (ja) 2017-01-17 2020-12-10 デイヴィッド フォレスト マイケル Atp合成酵素のリバースモードの治療的阻害剤
BR112019028172A2 (pt) 2017-07-13 2020-10-06 Michael David Forrest moduladores terapêuticos do modo reverso da atp sintase
EP3688770A1 (en) * 2017-09-28 2020-08-05 Koninklijke Philips N.V. System and method for detecting stroke in patients during pressure support therapy
US10980788B2 (en) 2018-06-08 2021-04-20 Agios Pharmaceuticals, Inc. Therapy for treating malignancies
CA3141612A1 (en) * 2019-05-22 2020-11-26 Enalare Therapeutics Inc. Methods and pharmaceutical compositions to treat drug overdose
KR20240004887A (ko) * 2021-05-04 2024-01-11 에날레어 테라퓨틱스 인크. 고전도도의 칼륨 채널 조정제, 이의 조성물, 이의 제조 방법, 및 이의 사용 방법
US12138267B2 (en) 2021-11-02 2024-11-12 Enalare Therapeutics Inc. Methods of treating respiratory depression modulated by a non-opioid agent
EP4456900A4 (en) * 2021-12-27 2025-12-24 Enalare Therapeutics Inc RESPIRATORY STIMULATING PARENTERAL FORMULATIONS

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3037980A (en) 1955-08-18 1962-06-05 Burroughs Wellcome Co Pyrrolopyrimidine vasodilators and method of making them
GB1001665A (en) 1961-06-05 1965-08-18 American Cyanamid Co Triazine derivatives and process for their preparation
DE69027440T2 (de) 1989-10-11 1997-02-06 Teijin Ltd Bizyklische pyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
JPH08272059A (ja) 1995-03-31 1996-10-18 Fuji Photo Film Co Ltd 多層ハロゲン化銀カラー写真感光材料包装体
JPH09189973A (ja) * 1996-01-08 1997-07-22 Fuji Photo Film Co Ltd ハロゲン化銀乳剤及びこれを用いる写真感光材料
JPH09251197A (ja) 1996-03-15 1997-09-22 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料
JPH09304898A (ja) 1996-05-15 1997-11-28 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料
IL143929A0 (en) * 1999-01-22 2002-04-21 Elan Pharm Inc Acyl derivatives which treat vla-4 related disorders
US6525067B1 (en) * 1999-11-23 2003-02-25 Pfizer Inc Substituted heterocyclic derivatives
AU2457201A (en) * 1999-12-28 2001-07-09 Bristol-Myers Squibb Company Cytokine, especially tnf-alpha, inhibitors
US20020065270A1 (en) * 1999-12-28 2002-05-30 Moriarty Kevin Joseph N-heterocyclic inhibitors of TNF-alpha expression
HUP0401712A3 (en) * 2001-06-26 2009-06-29 Bristol Myers Squibb Co N-heterocyclic inhibitors of tnf-alpha and pharmaceutical compositions containing them
BR0212895A (pt) * 2001-09-21 2005-05-10 Reddy Us Therapeutics Inc Métodos e composições de novos compostos de triazina
US20030168629A1 (en) * 2001-12-10 2003-09-11 Lazar Warren G. Reactive liquid polymer crosslinking agent and process for preparation
PT1946776T (pt) 2002-02-27 2017-03-17 Immunex Corp Composição de tnfr-fc estabilizada compreendendo arginina
MXPA04010983A (es) 2002-05-06 2005-02-14 Genelabs Tech Inc Derivados de nucleosidos para tratar infecciones por el virus de la hepatitis c.
TW200418498A (en) 2002-09-30 2004-10-01 Genelabs Tech Inc Nucleoside derivatives for treating hepatitis C virus infection
US7384937B2 (en) 2002-11-06 2008-06-10 Bristol-Myers Squibb Co. Fused heterocyclic compounds and use thereof
CN1826328A (zh) * 2003-07-22 2006-08-30 神经能质公司 经取代的吡啶-2-基胺类似物
CN1926140A (zh) * 2004-03-05 2007-03-07 大正制药株式会社 吡咯并嘧啶衍生物
WO2005090469A1 (en) 2004-03-15 2005-09-29 Honeywell International Inc. Cellulose reinforced resin compositions
WO2006023702A2 (en) 2004-08-20 2006-03-02 Cypress Bioscience, Inc. Method for treating sleep related breathing disorders with setiptiline
CN101495464B (zh) * 2005-12-29 2014-03-05 詹森药业有限公司 激肽原1受体拮抗剂
US8227466B2 (en) * 2006-05-17 2012-07-24 Albert Einstein College Of Medicine Of Yeshiva University Prostaglandin transporter inhibitors
GB0610317D0 (en) 2006-05-24 2006-07-05 Medical Res Council Antiparasitic compounds and compositions
EP1889847A1 (en) * 2006-07-10 2008-02-20 DeveloGen Aktiengesellschaft Pyrrolopyrimidines for pharmaceutical compositions
EP2059512A1 (en) * 2006-08-01 2009-05-20 Praecis Pharmaceuticals Incorporated P38 kinase inhibitors
WO2008024978A2 (en) 2006-08-24 2008-02-28 Serenex, Inc. Tetrahydroindolone and tetrahydroindazolone derivatives
JP2010509233A (ja) * 2006-11-03 2010-03-25 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー 新規sEH阻害剤およびそれらの使用
WO2009115084A2 (de) 2008-03-20 2009-09-24 Schebo Biotech Ag Neue pyrrolopyrimidin-derivate und deren verwendungen
CN101885707B (zh) * 2009-05-15 2012-08-29 中国科学院化学研究所 三嗪类衍生物及其制备方法与作为杀虫剂的用途

Similar Documents

Publication Publication Date Title
JP2013544285A5 (cg-RX-API-DMAC7.html)
JP5907986B2 (ja) 呼吸制御障害または呼吸制御疾患の処置用の呼吸刺激薬としての化合物
US9162992B2 (en) Compounds and compositions for treatment of breathing control disorders or diseases
JP4969010B2 (ja) Hiv複製阻害性ピリミジンのプロドラッグ
US8629153B2 (en) Use of quinazoline derivatives for the treatment of viral diseases
ES2377947T3 (es) Compuestos de pirimidina como inhibidores de la interleucina 12 (IL-12)
EA005423B1 (ru) Противовирусные композиции
WO2009009501A4 (en) Non-basic melanin concentrating hormone receptor-1 antagonists and methods
RU2014115290A (ru) Производные 1-фенил 2-пиридинилалкиловых спиртов в качестве ингибиторов
US7851466B2 (en) Pyrimidine compounds and uses thereof
JP2015521201A5 (cg-RX-API-DMAC7.html)
WO2014151462A4 (en) Novel breathing control modulating compounds, and methods of using same
JP6141334B2 (ja) ヒト呼吸器多核体ウイルス(rsv)の阻害剤として有用なジアミノピリミジン
JP2015521201A (ja) 呼吸制御障害または呼吸制御疾患の処置用の新規化合物および組成物
JPWO2020211839A5 (cg-RX-API-DMAC7.html)
EP2413940A1 (en) Compositions comprising 2, 4, 6-triamino-1, 3, 5-triazine derivatives for treatment of schizophrenia
MXPA00009436A (en) Trisubstituted 1,3,5-triazine derivatives for treatment of hiv infections